东宝生物(300239)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300239 东宝生物

已收盘 10-18 15:00:00

{"stockData":{"symbol":"300239","market":"SZ","secType":"STK","nameCN":"东宝生物","latestPrice":5.22,"timestamp":1729235016000,"preClose":5.07,"halted":0,"volume":15664549,"delay":0,"floatShares":590000000,"shares":594000000,"eps":0.179,"marketStatus":"已收盘","marketStatusCode":5,"change":0.15,"latestTime":"10-18 15:00:00","open":5.08,"high":5.29,"low":5.05,"amount":80975700,"amplitude":0.0473,"askPrice":5.22,"askSize":95,"bidPrice":5.21,"bidSize":1287,"shortable":0,"etf":0,"ttmEps":0.179,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1729474200000},"adr":0,"adjPreClose":5.07,"symbolType":"stock","openAndCloseTimeList":[[1729215000000,1729222200000],[1729227600000,1729234800000]],"highLimit":5.58,"lowLimit":4.56,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":593606491,"pbRate":1.8,"roa":"--","roe":"3.05%","epsLYR":0.202,"committee":-0.004037,"marketValue":3099000000,"floatMarketCap":3078000000,"peRate":29.16201,"changeRate":0.0296,"turnoverRate":0.0266,"status":0},"requestUrl":"/m/hq/s/300239/tweets","defaultTab":"tweets","newsList":[{"id":"2476725387","title":"东宝生物(300239.SZ)股东百纳盛远合计减持1.14%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2476725387","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476725387?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:48","pubTimestamp":1729259316,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)发布公告，股东海南百纳盛远科技有限公司(简称“百纳盛远”)于2024年10月16日通过集中竞价方式和大宗交易方式合计减持公司股票675.20万股，占公司总股本的1.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0239","300239","BK0028"],"gpt_icon":0},{"id":"2475937865","title":"10月16日东宝生物发生1笔大宗交易 成交金额2745.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475937865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475937865?lang=zh_cn&edition=full","pubTime":"2024-10-16 16:43","pubTimestamp":1729068202,"startTime":"0","endTime":"0","summary":"证券之星消息，10月16日东宝生物发生大宗交易，交易数据如下：大宗交易成交价格4.63元，相对当日收盘价折价9.92%，成交593万股，成交金额2745.59万元，买方营业部为中信证券股份有限公司杭州凤起路证券营业部，卖方营业部为中信建投证券股份有限公司内蒙古分公司。近三个月该股共发生2笔大宗交易，合计成交7.71万手，折价成交2笔。截至2024年10月16日收盘，东宝生物报收于5.14元，下跌0.19%，换手率1.59%，成交量9.37万手，成交额4820.71万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600025683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300239","BK0239","BK0077"],"gpt_icon":0},{"id":"2468759233","title":"东宝生物（300239）9月18日主力资金净买入78.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468759233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468759233?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:20","pubTimestamp":1726644029,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月18日收盘，东宝生物报收于4.5元，上涨2.27%，换手率1.51%，成交量8.93万手，成交额3965.09万元。9月18日的资金流向数据方面，主力资金净流入78.38万元，占总成交额1.98%，游资资金净流入358.82万元，占总成交额9.05%，散户资金净流出437.19万元，占总成交额11.03%。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800016382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300239","BK0028"],"gpt_icon":0},{"id":"2466557248","title":"东宝生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2466557248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466557248?lang=zh_cn&edition=full","pubTime":"2024-09-12 13:48","pubTimestamp":1726120095,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日包头东宝生物技术股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来包头东宝生物技术股份有限公司新申请注册商标3件，截止目前公司共持有注册商标314件，另有12件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200017503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300239","BK0239","BK0028"],"gpt_icon":0},{"id":"2466092407","title":"国恩股份最新公告：控股子公司东宝生物拟收购益青生物剩余股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2466092407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466092407?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:30","pubTimestamp":1726054222,"startTime":"0","endTime":"0","summary":"国恩股份公告，控股子公司东宝生物拟收购公司及德裕生物所持有的益青生物剩余964.00万股股份（占益青生物总股本的40%），交易总价款为2.32亿元。交易完成后，益青生物将成为东宝生物的全资子公司。其中，东宝生物收购公司持有的益青生物804.00万股股份，交易价款为1.935亿元；东宝生物收购德裕生物持有的益青生物160.00万股股份，交易价款为3850万元。本次交易构成关联交易。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100034809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0220","BK0186","300239","002768","BK0239","BK0181","BK0028"],"gpt_icon":0},{"id":"2466021164","title":"东宝生物最新公告：拟2.32亿元收购益青生物剩余40%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2466021164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466021164?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:10","pubTimestamp":1726053008,"startTime":"0","endTime":"0","summary":"东宝生物公告，公司拟收购国恩股份、德裕生物所持有的益青生物剩余964.00万股股份（占益青生物总股本的40%），交易价款为2.32亿元。交易完成后，东宝生物将持有益青生物100%的股份。国恩股份和德裕生物均为公司关联法人，本次交易构成关联交易。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100033820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","300239","BK0239"],"gpt_icon":0},{"id":"2466041374","title":"东宝生物(300239.SZ)拟2.32亿元收购益青生物剩余股份 提高运营管理效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2466041374","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466041374?lang=zh_cn&edition=full","pubTime":"2024-09-11 18:59","pubTimestamp":1726052380,"startTime":"0","endTime":"0","summary":"东宝生物(300239.SZ)公告，公司现持有益青生物60%的股份，公司拟收购少数...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1182093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0028","BK0077","300239","BK0239"],"gpt_icon":0},{"id":"2464790458","title":"东宝生物最新公告：股东计划减持不超过2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464790458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464790458?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:49","pubTimestamp":1725360586,"startTime":"0","endTime":"0","summary":"东宝生物公告，持股7.61%的股东百纳盛远计划以集中竞价或大宗交易的方式减持其持有的公司股份不超过1187.2万股(不超过公司总股本的2%)。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300031041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2464876739","title":"东宝生物：股东计划减持不超过2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464876739","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464876739?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:43","pubTimestamp":1725360212,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0028","BK0077","300239","BK0239"],"gpt_icon":0},{"id":"2464962876","title":"东宝生物(300239.SZ)股东百纳盛远拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464962876","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464962876?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:30","pubTimestamp":1725359424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)公告，公司持股5%以上股东百纳盛远拟以集中竞价或大宗交易的方式减持其持有的公司股份不超过1187.2万股(不超过公司总股本的2%)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300239","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2463726265","title":"东宝生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2463726265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463726265?lang=zh_cn&edition=full","pubTime":"2024-08-31 14:00","pubTimestamp":1725084045,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日包头东宝生物技术股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来包头东宝生物技术股份有限公司新申请注册商标2件，截止目前公司共持有注册商标314件，另有11件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100012784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239","BK0077","BK0239","BK0028"],"gpt_icon":0},{"id":"2462019487","title":"东宝生物最新公告：上半年净利润为5134.18万元 同比减少21.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462019487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462019487?lang=zh_cn&edition=full","pubTime":"2024-08-27 22:40","pubTimestamp":1724769640,"startTime":"0","endTime":"0","summary":"东宝生物发布2024年半年度报告，报告期公司营业收入为4.44亿元，同比减少14.68%。归属于上市公司股东的净利润为5134.18万元，同比减少21.02%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700041400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239"],"gpt_icon":0},{"id":"2462695081","title":"东宝生物(300239.SZ)发布上半年业绩，净利润5134.18万元，下降21.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462695081","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462695081?lang=zh_cn&edition=full","pubTime":"2024-08-27 19:54","pubTimestamp":1724759656,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)发布2024年半年度报告，该公司营业收入为4.44亿元，同比减少14.68%。归属于上市公司股东的净利润为5134.18万元，同比减少21.02%。归属于上市公司股东的扣除非经常性损益的净利润为4606.3万元，同比减少26.47%。基本每股收益为0.0865元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1172165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300239"],"gpt_icon":0},{"id":"2458756313","title":"东宝生物：8月9日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2458756313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458756313?lang=zh_cn&edition=full","pubTime":"2024-08-09 18:41","pubTimestamp":1723200100,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年8月9日东宝生物发布公告称公司于2024年8月9日召开业绩说明会。公司将持续关注其质押变动情况，并按相关规定及时履行信息披露义务。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。东宝生物2024年一季报显示，公司主营收入2.42亿元，同比下降7.48%；归母净利润2596.15万元，同比下降16.62%；扣非净利润2362.23万元，同比下降21.61%；负债率30.23%，投资收益-115.87万元，财务费用-170.04万元，毛利率20.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900041134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300239","BK0028"],"gpt_icon":0},{"id":"2458532784","title":"东宝生物（300239）8月9日主力资金净买入40.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458532784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458532784?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:27","pubTimestamp":1723188425,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月9日收盘，东宝生物报收于4.69元，下跌2.7%，换手率2.37%，成交量13.99万手，成交额6793.56万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：东宝生物2024年一季报显示，公司主营收入2.42亿元，同比下降7.48%；归母净利润2596.15万元，同比下降16.62%；扣非净利润2362.23万元，同比下降21.61%；负债率30.23%，投资收益-115.87万元，财务费用-170.04万元，毛利率20.84%。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900025917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300239","BK0077"],"gpt_icon":0},{"id":"2457865257","title":"东宝生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2457865257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457865257?lang=zh_cn&edition=full","pubTime":"2024-08-07 13:49","pubTimestamp":1723009790,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日包头东宝生物技术股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来包头东宝生物技术股份有限公司新申请注册商标1件，截止目前公司共持有注册商标314件，另有10件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700025868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2456479880","title":"8月2日东宝生物发生1笔大宗交易 成交金额831.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456479880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456479880?lang=zh_cn&edition=full","pubTime":"2024-08-02 16:50","pubTimestamp":1722588628,"startTime":"0","endTime":"0","summary":"证券之星消息，8月2日东宝生物发生大宗交易，交易数据如下：大宗交易成交价格4.67元，相对当日收盘价折价2.1%，成交178万股，成交金额831.26万元，买方营业部为广发证券股份有限公司上海控江路证券营业部，卖方营业部为中信建投证券股份有限公司荆州北京西路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1.78万手，折价成交1笔。截至2024年8月2日收盘，东宝生物报收于4.77元，上涨1.27%，换手率1.01%，成交量5.97万手，成交额2850.78万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200033215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","300239"],"gpt_icon":0},{"id":"2455665109","title":"东宝生物：您所说的该APP的数据非我公司财务数据。公司具体业绩情况详见公司于巨潮资讯网披露的相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2455665109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455665109?lang=zh_cn&edition=full","pubTime":"2024-07-29 20:01","pubTimestamp":1722254478,"startTime":"0","endTime":"0","summary":"您所说的该APP的数据非我公司财务数据。公司具体业绩情况详见公司于巨潮资讯网披露的相关公告，感谢您的关注。东宝生物董秘：尊敬的投资者您好，益青生物是公司控股子公司，要纳入合并报表范围，母子公司之间的交易均要全部抵消，因此不属于5大之一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900031602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300239","BK0239","BK0077"],"gpt_icon":0},{"id":"2444045619","title":"东宝生物（300239）6571.1万股限售股将于6月17日解禁，占总股本11.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444045619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444045619?lang=zh_cn&edition=full","pubTime":"2024-06-17 08:02","pubTimestamp":1718582562,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，东宝生物于6月17日将有6571.1万股限售股份解禁，为公司定向增发机构配售股份，占公司总股本11.07%。本次解禁后，公司还有400.12万股限售股份，占总股本0.67%。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061700000545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239","BK0239","BK0077","BK0028"],"gpt_icon":0},{"id":"2442530466","title":"【东宝生物(300239.SZ)约6571.1万股限售股将于6月17日上市流通】智通财经APP讯，东宝生物(300239.","url":"https://stock-news.laohu8.com/highlight/detail?id=2442530466","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442530466?lang=zh_cn&edition=full","pubTime":"2024-06-12 19:45","pubTimestamp":1718192720,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0077","BK0239","300239","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-07-06","address":"内蒙古自治区包头市九原区稀土高新技术产业开发区黄河大街46号","stockEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":0.16},{"period":"3month","weight":0.1226},{"period":"6month","weight":0.1085},{"period":"1year","weight":-0.132},{"period":"ytd","weight":-0.1585}],"companyName":"包头东宝生物技术股份有限公司","boardCode":"AI0027","perCapita":"24295股","boardName":"医药制造业","registeredCapital":"59360万元","compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.2003},{"period":"3month","weight":0.0936},{"period":"6month","weight":0.064},{"period":"1year","weight":0.0852},{"period":"ytd","weight":0.0963}],"survey":"　　包头东宝生物技术股份有限公司主要从事明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。公司主要产品及服务为TOB端业务和TOC端业务。公司曾荣获“内蒙古品牌建设标杆企业”、“全国明胶行业先进企业”、“2021年度中国明胶行业突出贡献奖”、“内蒙古老字号”、“内蒙古自治区农牧业产业化重点龙头企业”、“内蒙古自治区主席质量奖”、包头市首批百年老店等荣誉。","serverTime":1729459271096,"listedPrice":9,"stockholders":"24268人(较上一季度减少5.77%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东宝生物(300239)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东宝生物(300239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东宝生物,300239,东宝生物股票,东宝生物股票老虎,东宝生物股票老虎国际,东宝生物行情,东宝生物股票行情,东宝生物股价,东宝生物股市,东宝生物股票价格,东宝生物股票交易,东宝生物股票购买,东宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东宝生物(300239)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东宝生物(300239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}